These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8637567)

  • 1. Screening for genetic mutations.
    Carlsson C; Jonsson M; Nordén B; Dulay MT; Zare RN; Noolandi J; Nielsen PE; Tsui LC; Zielenski J
    Nature; 1996 Mar; 380(6571):207. PubMed ID: 8637567
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
    Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
    Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic screening and testing by induced heteroduplex formation.
    Wood N; Bidwell J
    Electrophoresis; 1996 Jan; 17(1):247-54. PubMed ID: 8907549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.
    Slostad J; Stein QP; Flanagan JD; Hansen KA
    Fertil Steril; 2007 Dec; 88(6):1687-8. PubMed ID: 17482604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The type and frequency of mutations in CFTR gene occurrence in patients with cystic fibrosis in Poland--implication of results obtained from genetic counseling and diagnostic screening].
    Bal J; Maciejko D; Mazurczak T
    Pediatr Pol; 1995 Aug; 70(8):627-32. PubMed ID: 8668362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
    Bobadilla JL; Farrell MH; Farrell PM
    Adv Pediatr; 2002; 49():131-90. PubMed ID: 12214770
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular diagnosis of cystic fibrosis.
    Kant JA; Mifflin TE; McGlennen R; Rice E; Naylor E; Cooper DL
    Clin Lab Med; 1995 Dec; 15(4):877-98. PubMed ID: 8838228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
    Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
    Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular basis of cystic fibrosis and congenital bilateral agenesis of vas deferens].
    Bienvenu T; Claustres M
    Contracept Fertil Sex; 1996 Jun; 24(6):495-500. PubMed ID: 8766513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.
    D'Apice MR; Gambardella S; Bengala M; Russo S; Nardone AM; Lucidi V; Sangiuolo F; Novelli G
    BMC Med Genet; 2004 Apr; 5():8. PubMed ID: 15084222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of northwestern Mexican patients with cystic fibrosis: screening of 10 known mutations. Mutations in brief no. 185. Online.
    Flores-Martínez SE; Dean M; Saiki RK; Gallegos-Arreola MP; Morán-Moguel MC; Sánchez-Corona J
    Hum Mutat; 1998; 12(3):217-8. PubMed ID: 10660336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina.
    Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS
    Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis in cystic fibrosis.
    Galvin P; Clarke LA; Harvey S; Amaral MD
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():29-33. PubMed ID: 15463921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis.
    Berwouts S; Gordon JT; Rundell CA; Barton DE; Dequeker E
    Hum Mutat; 2008 Aug; 29(8):1063-70. PubMed ID: 18470946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative genetic neonatal screening for cystic fibrosis caused by compound heterozygosity for two large CFTR rearrangements.
    Girardet A; Guittard C; Altieri JP; Templin C; Stremler N; Beroud C; des Georges M; Claustres M
    Clin Genet; 2007 Oct; 72(4):374-7. PubMed ID: 17850636
    [No Abstract]   [Full Text] [Related]  

  • 18. DHPLC screening of cystic fibrosis gene mutations.
    Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
    Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFTR mutations in patients from Colombia: implications for local and regional molecular diagnosis programs.
    Keyeux G; Rodas C; Bienvenu T; Garavito P; Vidaud D; Sanchez D; Kaplan JC; Aristizábal G
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of frequent mutations of the CFTR gene in cystic fibrosis patients from Central Russia].
    Petrova NV; Kapranov NI; Ginter EK
    Genetika; 1997 Jan; 33(1):106-9. PubMed ID: 9162681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.